Clinical Trials

13 enrolled

Neoplasm Metastasis

NCT02387905 2026-04-15

Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases

87 enrolled

Neoplasm Metastasis

NCT04957615 2026-04-15

Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression

16 enrolled

Neoplasm Metastasis

NCT05347212 2026-04-15

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

30 enrolled

Carcinoma

NCT06669572 2026-04-15

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Carcinoma, Squamous Cell

NCT05821556 2026-04-14

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

240 enrolled

Neoplasm Metastasis

NCT05879146 2026-04-13

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

40 enrolled

Neoplasms

NCT06319378 2026-04-13

CAPSI

100 enrolled

Neoplasms

NCT06790602 2026-04-09

SWITCH

43 enrolled

Neoplasm Metastasis

NCT07284589 2026-04-08

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

200 enrolled

Neoplasms

NCT07346209 2026-04-08

STRIPe

280 enrolled

Neoplasm Metastasis

NCT06939452 2026-04-07

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

37 enrolled

Adenocarcinoma

NCT06152523 2026-04-06

MONAMI

Phase 2 Withdrawn

Neoplasms

NCT07511023 2026-04-06

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

20 enrolled

Neoplasm Metastasis

NCT04309578 2026-04-03

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

28 enrolled

Adenocarcinoma

NCT07483983 2026-03-27

UNLOCK ASP3082

60 enrolled

Neoplasm Metastasis

NCT07487805 2026-03-23

ICONIC

80 enrolled

Neoplasms

NCT05027633 2026-03-20

Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

Carcinoma, Squamous Cell

NCT06788938 2026-03-20

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

29 enrolled

Neoplasms

NCT06658405 2026-03-18

HPV2

85 enrolled

Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

88 enrolled

Neoplasms

NCT06807593 2026-03-05

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

10 enrolled

Neoplasms

NCT05148078 2026-03-02

Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)

30 enrolled 10 charts

Neoplasms

NCT06435286 2026-03-02

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

200 enrolled

Neoplasms

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT07431073 2026-02-24

METAREM

275 enrolled

Neoplasm Metastasis

NCT04150900 2026-02-19

1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

7 enrolled 11 charts

Carcinoma, Squamous Cell

NCT06754501 2026-02-18

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary

4 enrolled

Neoplasms

NCT05117931 2026-02-17

A Study of Amivantamab in People With Esophagogastric Cancer

25 enrolled

Neoplasm Metastasis

NCT03388190 2026-02-13

METIMMOX

80 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT06358677 2026-02-13

FACE

25 enrolled

Neoplasm Metastasis

NCT06778408 2026-02-05

HART

103 enrolled

Neoplasm Metastasis

NCT06417190 2026-02-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

20 enrolled

Neoplasms

NCT07381231 2026-02-02

I-APT

Neoplasms

NCT07378761 2026-01-30

CHILURSO

94 enrolled

Neoplasms

NCT06693128 2026-01-28

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

80 enrolled

Adenocarcinoma

NCT05502315 2026-01-23

CANOPY

47 enrolled

Neoplasm Metastasis

NCT06323473 2026-01-23

Maitake

40 enrolled

Neoplasms

NCT03752333 2026-01-22

CUPem

Neoplasms, Unknown Primary

NCT04948619 2026-01-22

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

64 enrolled

Neoplasms

NCT06967987 2026-01-21

BEMAFLOT

Phase 2 Withdrawn

Adenocarcinoma

NCT07356791 2026-01-21

REBIRTH-013

18 enrolled

Neoplasms

NCT05933395 2026-01-20

GERTRUDE

135 enrolled

Neoplasm Metastasis

NCT07346196 2026-01-20

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

90 enrolled

Carcinoma, Squamous Cell

NCT07335237 2026-01-13

Clinical Study on the Prevention and Treatment of Postoperative Gastrointestinal Dysfunction by Acupuncture Under ERAS Management Based on Artificial Intelligence Monitoring

70 enrolled

Neoplasms

NCT06201884 2026-01-12

APPAHOCA-2

60 enrolled

Neoplasms

NCT07126561 2026-01-08

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

43 enrolled

Neoplasm Metastasis, Neoplasms

NCT04795661 2026-01-07

IMHOTEP

240 enrolled

Neoplasms

NCT06162351 2026-01-02

TOPOLOGY

Phase 2 Terminated

14 enrolled

Neoplasm Metastasis, Neoplasms

NCT03583255 2025-12-26

Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer

99 enrolled